홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

Propionyl CoA

HCID 92753
노트반응
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
317-66-8
표준 SMILES
CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O
InChIKey
QAQREVBBADEHPA-IEXPHMLFSA-N
분자식
C24H40N7O17P3S
평균 분자량
823.6 g/mol
단동위원소 질량
823.141425

개요

Propionyl-CoA is an acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of propionic acid. It has a role as a metabolite, a mouse metabolite and an Escherichia coli metabolite. It is functionally related to a coenzyme A and a propionic acid. It is a conjugate acid of a propionyl-CoA(4-).

이름 및 식별자

우선 이름
Propionyl CoA
IUPAC
S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] propanethioate
영어명
S-propionylcoenzyme A
분자식
C24H40N7O17P3S
분자량
823.6

이름 및 동의어

propionyl-CoAPropionyl coenzyme APropionyl CoApropionyl-coenzyme A317-66-8propanoyl-CoApropanoyl-coenzyme AS-propanoyl-CoAS-propanoyl-coenzyme AS-Propionyl-coenzym-AH7HQA57V5HDTXSID10185594
이름 더 보기
03:0 Coenzyme AS-propionylcoenzyme ACoenzyme A, S-propanoatePropionyl-CoA-sodium-saltPropionyl-CoenzymeA-Na?SaltS-propionylcoenzyme A / Propanoyl coenzyme A[5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[3-hydroxy-2,2-dimethyl-3-[2-(2-propanoylsulfanylethylcarbamoyl)ethylcarbamoyl]propoxy]-phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid
CHEBI:155393'-phosphoadenosine 5'-(3-{(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[(3-oxo-3-{[2-(propanoylsulfanyl)ethyl]amino}propyl)amino]butyl} dihydrogen diphosphate){[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-2,2-dimethyl-3-[(2-{[2-(propanoylsulfanyl)ethyl]carbamoyl}ethyl)carbamoyl]propoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acidS-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] propanethioatecoenzyme A, propionyl-(((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-(((hydroxy((hydroxy((3R)-3-hydroxy-2,2-dimethyl-3-((2-((2-(propanoylsulfanyl)ethyl)carbamoyl)ethyl)carbamoyl)propoxy)phosphoryl)oxy)phosphoryl)oxy)methyl)oxolan-3-yl)oxy)phosphonic acid3'-phosphoadenosine 5'-(3-((3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-((3-oxo-3-((2-(propanoylsulfanyl)ethyl)amino)propyl)amino)butyl) dihydrogen diphosphate)S-(2-(3-(((2R)-4-((((2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl)methoxy-hydroxyphosphoryl)oxy-hydroxyphosphoryl)oxy-2-hydroxy-3,3-dimethylbutanoyl)amino)propanoylamino)ethyl) propanethioate

데이터베이스 식별자

CAS
317-66-8
PubChem CID
92753
DTXSID
DTXSID10185594
ChEBI
CHEBI:15539
UNII
H7HQA57V5H
EC Number
206-266-6
Nikkaji
J1.695.704F

물성

구조 계산 물성

XLogP
-5.1
극성 표면적
389 Ų
수소 결합 공여자 수
9
수소 결합 수용자 수
22
회전 가능 결합 수
21
무거운 원자 수
52
형식 전하
0
복잡도
1,400

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15
LipidsFatty Acyls [FA] -> Fatty esters [FA07] -> Fatty acyl CoAs [FA0705]
Physical DescriptionSolid

물리화학적 성질

밀도
1.866 · 1.866±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
저장 조건
-20 °C · -20°C
물리적 상태
powder
산도 계수 (pKa)
1.157 · 1.157±0.50(predicted)
주요 응용
리피도믹스
InChIKey
QAQREVBBADEHPA-UHFFFAOYSA-N
SMILES
O[C@@](C(NCCC(NCCSC(CC)=O)=O)=O)(C(C)(COP([O-])(OP([O-])(OC[C@H]([C@H]1OP([O-])(O)=O)O[C@H]([C@@H]1O)N2C3=C(C(N)=NC=N3)N=C2)=O)=O)C)[H].[Na+].[Na+].[Na+]

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

독성 정보

TreatmentThe carnitine deficiency associated with propionic acuduria demands supplementation of free carnitine above the normal dietary intake to continue to remove (detoxify) the accumulating organic acids.
Health EffectsPropionic acidemia presents in the early neonatal period with progressive encephalopathy. Death can occur quickly, due to secondary hyperammonemia, infection, cardiomyopathy, or basal ganglial stroke. (Wikipedia)
Toxicity Summary · 1건

In propionic aciduria, propionyl CoA accumulates within the mitochondria in massive quantities; free carnitine is then esterified, creating propionyl carnitine, which is then excreted in the urine. Because the supply of carnitine in the diet and from synthesis is limited, such patients readily develop carnitine deficiency as a result of the increased loss of acylcarnitine derivatives.

Signs and Symptoms · 1건

Propionic acidemia is characterized almost immediately in newborns. Symptoms include poor feeding, vomiting, dehydration, acidosis, low muscle tone (hypotonia), seizures, and lethargy. The effects of propionic acidemia quickly become life-threatening. (Wikipedia)

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

안전 데이터

wgk
WGK 3
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

Metabolism/Metabolites · 1건

Metabolism of organophosphates occurs principally by oxidation, by hydrolysis via esterases and by reaction with glutathione. Demethylation and glucuronidation may also occur. Oxidation of organophosphorus pesticides may result in moderately toxic products. In general, phosphorothioates are not directly toxic but require oxidative metabolism to the proximal toxin. The glutathione transferase reactions produce products that are, in most cases, of low toxicity. Paraoxonase (PON1) is a key enzyme in the metabolism of organophosphates. PON1 can inactivate some organophosphates through hydrolysis. PON1 hydrolyzes the active metabolites in several organophosphates insecticides as well as, nerve agents such as soman, sarin, and VX. The presence of PON1 polymorphisms causes there to be different enzyme levels and catalytic efficiency of this esterase, which in turn suggests that different individuals may be more susceptible to the toxic effect of organophosphate exposure.

Cellular LocationsCytoplasm
Metabolite Pathways2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency

용도 및 제조

UsesThis is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation.

공급사15 곳

浙江珲达生物科技有限公司0571-89903022 18679456698 · [email protected]
上海梅凯科技有限公司021-68689288 15300790979 · [email protected]
湖北扬信医药科技有限公司15347293736 · [email protected]
南京政琦科技有限公司19853943728 19853943728 · [email protected]
浙江珲达生物科技有限公司0571-89903022 18679456698 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
成都标样生物科技有限公司028-81700200 13308200041 · [email protected]
河南阿尔法化工有限公司0371-55051623 18137891487 · [email protected]
河南伊诺凯新材料有限公司15565215982 15565215982 · [email protected]
上海贝万塔生物科技有限公司021-67187366 19901745723 · [email protected]
BOC Sciences+1-631-485-4226 · [email protected]
上海楷森生物科技有限公司17558870519 · [email protected]
广东翁江化学试剂有限公司0751-2815983 13927872582 · [email protected]
南通信合生物科技有限公司13813727166,15370460228; 13813727166 · [email protected]
上海甄准生物科技有限公司18019219489 18901678489 · [email protected]

추가 설명

정의ChEBI: An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of propionic acid.

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트